Qurate Retail, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of number and weighted average GDFV of option granted


	Three months ended
	March 31, 2023
	RSUs Granted (000's)	Weighted Average GDFV

Series A Qurate Retail common stock, subsidiary employees (1)	935	$	0.89
Series A Qurate Retail common stock, Qurate Retail employees and directors (2)	553	$	1.51
Series A Qurate Retail common stock, Qurate Retail President and CEO (3)	1,869	$	1.51
Series B Qurate Retail common stock, Qurate Retail Chairman of the Board (4)	353	$	5.51

(1)

Grant vests equally over three years.

(2)

Grants mainly vest one year from the month of grant, subject to the satisfaction of certain performance objectives.

(3)

Grant vests one year from the month of grant, subject to the satisfaction of certain performance objectives. Grant was made in connection with the employment agreement of our President and Chief Executive Officer.

(4)

Grant vests one year from the month of grant, subject to the satisfaction of certain performance objectives. Grant was made in connection with our Chairman’s employment agreement.

Schedule of number and weighted average GDFV of RSUs granted to certain officers, employees and directors


		Weighted			Weighted
	Series A	Average		Series B	Average
	(000's)	GDFV		(000's)	GDFV
RSUs outstanding at January 1, 2023	23,166	$	5.09	327	$	4.95
Granted	3,357	$	1.34	353	$	5.51
Vested	(5,544)	$	6.37	(327)	$	4.95
Forfeited/Cancelled	(1,850)	$	5.71	—	$	—
RSUs outstanding at March 31, 2023	19,129	$	4.00	353	$	5.51

Common Class A

Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards



				Weighted		Aggregate
				average		intrinsic
	Series A			remaining		value
	(000's)	WAEP		life		(millions)
Options outstanding at January 1, 2023	32,914	$	8.78
Granted	—	$	—
Exercised	(14)	$	2.17
Forfeited/Cancelled	(4,016)	$	12.90
Options outstanding at March 31, 2023	28,884	$	8.21	2.9	years	$	—
Options exercisable at March 31, 2023	18,954	$	9.61	2.3	years	$	—

Common Class B

Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards



				Weighted		Aggregate
				average		intrinsic
	Series B			remaining		value
	(000's)	WAEP		life		(millions)
Options outstanding at January 1, 2023	2,221	$	12.25
Granted	—	$	—
Exercised	—	$	—
Forfeited/Cancelled	(1,498)	$	12.20
Options outstanding at March 31, 2023	723	$	12.35	1.6	years	$	—
Options exercisable at March 31, 2023	723	$	12.35	1.6	years	$	—